🇺🇸 FDA
Patent

US 6309634

Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)

expired A61KA61K31/198A61K35/761

Quick answer

US patent 6309634 (Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)) held by The Regents of the University of California expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/198, A61K35/761, A61K38/45, A61K38/51